PharmaResearch Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2015
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2015
Operating Revenue	296,594	261,011	194,759	154,083	108,746	83,872	Upgrade
Other Revenue	-0	-0	-0	-0	-	-	Upgrade
Revenue	296,594	261,011	194,759	154,083	108,746	83,872	Upgrade
Revenue Growth (YoY)	33.58%	34.02%	26.40%	41.69%	29.66%	30.48%	Upgrade
Cost of Revenue	85,590	70,753	53,246	45,750	35,850	33,766	Upgrade
Gross Profit	211,004	190,258	141,513	108,333	72,896	50,106	Upgrade
Selling, General & Admin	78,818	73,828	58,572	42,832	29,604	21,287	Upgrade
Research & Development	17,727	15,030	8,702	6,738	5,543	5,614	Upgrade
Other Operating Expenses	519.35	556.23	648.65	313.55	240.17	-418.95	Upgrade
Operating Expenses	105,704	98,001	75,597	55,844	39,471	31,043	Upgrade
Operating Income	105,300	92,258	65,916	52,489	33,426	19,062	Upgrade
Interest Expense	-1,341	-2,987	-3,830	-1,314	-1,787	-2,343	Upgrade
Interest & Investment Income	7,526	7,403	5,272	3,726	2,098	2,208	Upgrade
Earnings From Equity Investments	6,597	-	-	-	-	-	Upgrade
Currency Exchange Gain (Loss)	1,095	-379.95	207.69	155.77	163.98	548.19	Upgrade
Other Non Operating Income (Expenses)	9,420	3,396	-3,220	124.32	4,338	-680.16	Upgrade
EBT Excluding Unusual Items	128,598	99,690	64,346	55,181	38,239	18,796	Upgrade
Gain (Loss) on Sale of Investments	-9,563	4,210	-5,023	1,462	2,907	-340.36	Upgrade
Gain (Loss) on Sale of Assets	-1.46	36.11	-113.69	229.6	-362.6	7.05	Upgrade
Asset Writedown	-3,217	-3,231	-5,161	-839.66	-1,246	-	Upgrade
Other Unusual Items	-	-	-	-	-	66.59	Upgrade
Pretax Income	115,817	100,705	54,048	56,033	39,537	18,529	Upgrade
Income Tax Expense	25,039	23,440	10,614	9,210	7,085	3,678	Upgrade
Earnings From Continuing Operations	90,778	77,265	43,434	46,824	32,452	14,851	Upgrade
Minority Interest in Earnings	-33.6	-713.44	-2,857	-134.98	322.11	1,817	Upgrade
Net Income	90,744	76,551	40,577	46,689	32,774	16,667	Upgrade
Net Income to Common	90,744	76,551	40,577	46,689	32,774	16,667	Upgrade
Net Income Growth	63.17%	88.66%	-13.09%	42.45%	96.64%	15.68%	Upgrade
Shares Outstanding (Basic)	10	10	10	10	10	9	Upgrade
Shares Outstanding (Diluted)	11	11	10	10	10	9	Upgrade
Shares Change (YoY)	11.98%	5.85%	-0.76%	5.74%	0.73%	-3.54%	Upgrade
EPS (Basic)	8886.91	7571.24	4067.47	4716.62	3447.46	1766.04	Upgrade
EPS (Diluted)	8280.92	7502.00	4067.00	4714.88	3447.00	1766.00	Upgrade
EPS Growth	48.95%	84.46%	-13.74%	36.78%	95.19%	16.35%	Upgrade
Free Cash Flow	79,197	52,883	42,147	44,652	-2,393	9,687	Upgrade
Free Cash Flow Per Share	7021.02	5008.17	4224.85	4441.83	-251.75	1026.37	Upgrade
Dividend Per Share	950.000	950.000	660.000	600.000	500.000	300.000	Upgrade
Dividend Growth	43.94%	43.94%	10.00%	20.00%	66.67%	0%	Upgrade
Gross Margin	71.14%	72.89%	72.66%	70.31%	67.03%	59.74%	Upgrade
Operating Margin	35.50%	35.35%	33.85%	34.07%	30.74%	22.73%	Upgrade
Profit Margin	30.60%	29.33%	20.83%	30.30%	30.14%	19.87%	Upgrade
Free Cash Flow Margin	26.70%	20.26%	21.64%	28.98%	-2.20%	11.55%	Upgrade
EBITDA	117,814	104,253	76,518	62,041	41,786	26,745	Upgrade
EBITDA Margin	39.72%	39.94%	39.29%	40.26%	38.43%	31.89%	Upgrade
D&A For EBITDA	12,514	11,996	10,602	9,552	8,360	7,683	Upgrade
EBIT	105,300	92,258	65,916	52,489	33,426	19,062	Upgrade
EBIT Margin	35.50%	35.35%	33.84%	34.07%	30.74%	22.73%	Upgrade
Effective Tax Rate	21.62%	23.28%	19.64%	16.44%	17.92%	19.85%	Upgrade
Advertising Expenses	-	22,601	18,381	9,339	5,711	2,918	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.